How to Get PRP Therapy Online in Cork
PRP Therapy is an experimental treatment currently in clinical trials. It is not yet approved by the European Medicines Agency (EMA) and is therefore not legally available in Cork or anywhere in the EU.

How to Get PRP Therapy Online in Cork
Many individuals in Cork and across the EU are exploring innovative options for weight management, and you might be wondering about obtaining PRP Therapy online. While interest in PRP Therapy for weight loss is growing, it's important to understand its current status. Hi-Doctor does not currently offer or prescribe PRP Therapy, as this treatment is still in clinical trials and is not yet approved for weight loss by the European Medicines Agency (EMA) or other major regulatory bodies. This means it is not legally available for prescription in Cork or anywhere in the EU. Instead, let's clarify what PRP Therapy actually is, why it's not a standard option yet, and guide you toward EU-approved, medically supervised weight-loss treatments that are available through EU-licensed doctors today.
What is PRP Therapy, and why isn't it a normal option yet?
PRP Therapy refers to a class of experimental treatments often discussed in the context of weight loss due to its potential impact on metabolic pathways. These therapies typically involve peptides that act as GLP-1, GIP, and potentially glucagon receptor agonists, aiming to regulate appetite, improve insulin sensitivity, and promote feelings of fullness. While early research shows promise, PRP Therapy is still firmly in the clinical trial stage. Neither the European Medicines Agency (EMA) nor the U.S. Food and Drug Administration (FDA) has granted approval for its use in weight management. This lack of regulatory approval means that any sources offering PRP Therapy online are operating outside of established medical and legal frameworks, posing significant safety risks due to potential counterfeits, incorrect dosages, and lack of medical oversight.
Proven weight-loss medications available online today
For those seeking effective, medically supervised weight loss, several EU-approved medications are available and have demonstrated significant results under a doctor's care.
- Ozempic (semaglutide): This GLP-1 receptor agonist helps manage blood sugar and promotes weight loss by reducing appetite and slowing gastric emptying. It is suitable for individuals with type 2 diabetes and obesity or overweight.
- Wegovy (semaglutide, higher-dose): A higher-dose formulation of semaglutide, Wegovy is specifically approved for chronic weight management in adults with obesity or overweight and related comorbidities.
- Mounjaro (tirzepatide): A dual GIP and GLP-1 receptor agonist, Mounjaro has shown superior weight loss compared to semaglutide in clinical trials, making it a powerful option for individuals with type 2 diabetes and obesity.
- Saxenda (liraglutide): This GLP-1 receptor agonist is prescribed for chronic weight management in adults with obesity or overweight, administered daily.
How to get a weight-loss prescription online in Cork, Ireland
Hi-Doctor offers a straightforward, supervised path to accessing EU-approved weight-loss treatments if they are right for you:
- Complete an online questionnaire: Start by filling out our brief 2–3 minute medical questionnaire confidentially within your secure Hi-Doctor account.
- EU-licensed doctor reviews your case: An experienced, EU-licensed doctor will thoroughly review your medical history and questionnaire responses to determine if a weight-loss treatment is appropriate for your individual health needs.
- Receive a REMPE prescription in <24 h: If approved, you'll receive a valid REMPE electronic prescription (the Spanish standard, valid EU-wide) as a downloadable PDF in your account and via email, typically within 24 hours. The €25 consultation fee is refunded automatically if the doctor determines treatment is not suitable.
- Pick up at any EU pharmacy: Present your digital or printed prescription at any pharmacy in any EU country, including those in Cork, Ireland, under the cross-border prescription directive 2011/24/EU.
Why choose Hi-Doctor over unregulated peptide sellers
When considering weight-loss treatments, safety, regulation, and traceability are paramount. Hi-Doctor provides a secure and legitimate pathway, contrasting sharply with the risks associated with unregulated 'research chemicals' or grey-market peptide vendors. With Hi-Doctor, you benefit from consultations with EU-licensed doctors, prescriptions for real medications filled at real pharmacies, and auditable, RGPD-compliant communication within your private account. We've served over 50,000 patients with a 4.8 Trustpilot rating, ensuring a trustworthy and medically sound experience, unlike the unknown origins and lack of medical oversight from unverified online sources.
Frequently asked questions
Is PRP Therapy legal to buy online in Spain?
No, PRP Therapy is not legally approved for prescription or sale for weight loss in Spain or any other EU country, as it remains an experimental treatment without regulatory approval.
When will PRP Therapy be available by prescription?
The timeline for PRP Therapy's prescription availability is uncertain, as it depends on successful completion of clinical trials and subsequent regulatory approval by bodies like the EMA. This process can take several years.
What's the closest approved alternative to PRP Therapy?
The closest approved alternatives are GLP-1 and GIP/GLP-1 receptor agonists like Ozempic, Wegovy, Mounjaro, and Saxenda, which are approved for weight management and work through similar metabolic pathways.
How much does an online weight-loss consultation cost?
An online weight-loss consultation with an EU-licensed doctor through Hi-Doctor costs a flat fee of €25. This fee is automatically refunded if the doctor determines that treatment is not appropriate for you.
Can I use a Hi-Doctor prescription at any pharmacy?
Yes, all Hi-Doctor prescriptions are valid REMPE electronic prescriptions that can be used at any pharmacy in any EU country, including Ireland, thanks to the EU's cross-border prescription directive 2011/24/EU.